Japanese Kampo Medicine · Traditional Chinese Medicine
Juzentaihoto (Ten Significant Tonic)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Juzentaihoto is a traditional Japanese Kampo formula containing ten herbs that modulates immune function through cytokine regulation and T-cell activation. This multi-herb blend primarily works by enhancing Th1/Th2 immune balance and supporting hematopoietic function.
Juzentaihoto is a Kampo formula originating from traditional Chinese medicine, consisting of ten herbs designed to strengthen the body and support recovery.
Research on Juzentaihoto includes studies that indicate its potential to boost immune function and improve recovery times. Some RCTs support its efficacy in specific conditions.
Juzentaihoto is typically taken in multiple doses throughout the day. Consult a healthcare provider before use.
Juzentaihoto (十全大補湯) is a complex polyherbal Kampo/TCM decoction comprising ten medicinal herbs, each contributing distinct bioactive compounds rather than conventional macronutrients. Key constituents and their approximate concentrations (per standard daily decoction dose of ~7.5 g dried extract): **Primary Herbs & Bioactive Compounds:** 1. **Astragalus root (Huangqi, ~3 g crude herb equivalent):** Astragaloside IV (~0.5–2 mg), cycloastragenol, astragalus polysaccharides (APS, ~50–100 mg), flavonoids (calycosin, formononetin ~1–5 mg). Immunomodulatory saponins with moderate oral bioavailability (~2–7% for astragaloside IV). 2. **Rehmannia root/Shu Di Huang (~3 g):** Catalpol (~5–15 mg), iridoid glycosides, rehmanniosides, amino acids. Catalpol bioavailability is moderate (~20–30%). 3. **Angelica sinensis/Dang Gui (~3 g):** Ferulic acid (~2–8 mg), Z-ligustilide (~5–15 mg), polysaccharides (~30–60 mg). Ferulic acid has high oral bioavailability (~40–60%). 4. **Paeonia lactiflora/Bai Shao (~3 g):** Paeoniflorin (~15–40 mg), albiflorin (~5–10 mg), benzoic acid. Paeoniflorin has low oral bioavailability (~3–5%) but is converted to paeonimetabolin-I by gut microbiota. 5. **Ligusticum chuanxiong/Chuan Xiong (~3 g):** Tetramethylpyrazine (ligustrazine, ~2–5 mg), ferulic acid (~1–3 mg), senkyunolide A (~1–4 mg). Ligustrazine bioavailability is moderate (~30%). 6. **Atractylodes macrocephala/Bai Zhu (~3 g):** Atractylenolide I, II, III (~1–5 mg total), atractylodes polysaccharides (~20–50 mg). 7. **Poria cocos/Fu Ling (~3 g):** Pachymic acid (~1–3 mg), poricoic acid, beta-glucan polysaccharides (~30–80 mg, including pachyman). Beta-glucans act as biological response modifiers with limited direct absorption but significant gut-immune interaction. 8. **Ginseng root/Ren Shen (~3 g):** Ginsenosides Rb1, Rg1, Re (~5–15 mg total), ginseng polysaccharides (~20–40 mg). Ginsenoside bioavailability is low (~1–5%) but enhanced by gut microbial metabolism to compound K. 9. **Cinnamomum cassia bark/Rou Gui (~1.5 g):** Cinnamaldehyde (~10–30 mg), cinnamic acid (~2–5 mg), coumarin (~1–3 mg), procyanidins. Cinnamaldehyde has good oral absorption (~65–75%). 10. **Glycyrrhiza uralensis/Gan Cao (~1.5 g):** Glycyrrhizin (~10–30 mg), liquiritigenin (~1–3 mg), isoliquiritigenin. Glycyrrhizin is hydrolyzed to glycyrrhetinic acid by gut bacteria with enhanced bioavailability. **Micronutrients (approximate per daily dose):** Iron (~2–5 mg, contributed primarily by Rehmannia and Angelica, moderate bioavailability enhanced by organic acid content), Potassium (~50–100 mg), Magnesium (~10–25 mg), Zinc (~0.5–1.5 mg), Manganese (~0.5–2 mg), trace Calcium (~15–30 mg). **Macronutrient content is negligible:** Protein <1 g, Fat <0.5 g, Carbohydrates ~3–5 g (mostly from polysaccharides and excipients), Dietary fiber ~0.5–1 g. Caloric value is approximately 15–25 kcal per daily dose. **Collective Polysaccharide Content:** ~150–350 mg total immunomodulatory polysaccharides per daily dose, acting synergistically on Peyer's patches and gut-associated lymphoid tissue. **Bioavailability Notes:** Overall, the multi-herb formulation exhibits pharmacokinetic synergy—Glycyrrhiza enhances absorption of multiple co-administered compounds via P-glycoprotein inhibition; Cinnamomum improves gastrointestinal blood flow aiding absorption; gut microbiota-mediated biotransformation is critical for activation of glycosides (paeoniflorin, ginsenosides, glycyrrhizin). The decoction form generally provides superior extraction and bioavailability compared to powdered herb preparations.
Juzentaihoto activates macrophages and enhances IL-2 and interferon-gamma production while modulating Th1/Th2 cytokine balance. The formula's polysaccharides from Astragalus and Atractylodes stimulate complement activation and NK cell activity. Key compounds including ginsenosides and glycyrrhizin work synergistically to enhance hematopoietic stem cell proliferation and differentiate immune cell populations.
Clinical studies involving 200-400 participants show Juzentaihoto reduces upper respiratory infection duration by 25% and enhances vaccine response in elderly populations. Multiple randomized controlled trials demonstrate improved white blood cell counts and cytokine profiles in cancer patients undergoing chemotherapy. However, most studies are conducted in Japanese populations with relatively small sample sizes. Evidence is strongest for immune support in immunocompromised individuals, though more large-scale international trials are needed.
Juzentaihoto is generally well-tolerated with mild gastrointestinal upset reported in 5-8% of users. The licorice component may cause pseudoaldosteronism with prolonged use, leading to elevated blood pressure and potassium depletion. It may interact with warfarin due to ginseng content and should be avoided with immunosuppressive medications. Pregnancy and breastfeeding safety has not been established, so use should be avoided during these periods.
